Federal health agencies have restored several webpages and datasets, following a judge's order to bring back public access to information that had been removed to comply with a presidential executive ...

On December 27, 2024, the US Food and Drug Administration (FDA) published its final rule to update the definition for “healthy” claims on food ...

President Donald Trump handed more power to Elon Musk yesterday. An American teacher was freed from captivity in Russia yesterday. A judge ordered the CDC and FDA to restore websites that were removed ...

A judge issued a temporary restraining order against the Trump administration, ordering it to restore numerous webpages that ...

White House reveals source of mysterious drones seen over New ... The 10 Wealthiest People on the Planet Crabgrass by Tauhid Bondia FDA approves first new type of pain medication in 25 years The best ...

As noted on the Food and Drug Administration (FDA) website in December: “Those with an allergy or severe sensitivity to milk run the risk of a serious or life-threatening allergic reaction if ...

Allogene Therapeutics (ALLO) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application for a rheumatology basket study of ALLO-329 ...

The Centers for Disease Control and Prevention is going dark, along with other federal agencies within the umbrella of the U.S. Department of Health and Human Services. This week, the returning Trump ...

Not all chemical hair relaxers include the chemical, but many include ingredients that can release formaldehyde when heated, the FDA said in 2024. Over the years, an increasing number of studies ...

However, it had to be used in conjunction with an oral medication. The FDA has now expanded its approval to include the standalone use of the nasal spray for adults with treatment-resistant major ...

CNN has reached out to the White House for comment. A spokesperson for the CDC and a spokesperson for the FDA referred CNN to HHS for comment. HHS has not responded to CNN’s request for comment.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...